Brief: FDA Pauses Start Of DIAGNODE-3 In US

Diamyd Medical AB

17/09/2021 11:22

Sept 17 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * FDA PAUSES START OF DIAGNODE-3 IN THE US PENDING
CLARIFICATION
ON STUDY DRUG
    * FDA PAUSES START OF PHASE III TO CLARIFY CERTAIN
OUTSTANDING
QUESTIONS REGARDING STUDY DRUG
    * FDA HAS INFORMED THAT IT DOES NOT YET HAVE SUFFICIENT
INFORMATION ON QUESTIONS CONCERNING STUDY DRUG
    * WILL BE NOTIFIED OF WHICH QUESTIONS THAT ARE OUTSTANDING
WITHIN
30 DAYS

Source text for Eikon:  ID:nWkr2xP7J5 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))